PATH
Menu

This paper was commissioned for the aids2031 Science and Technology Working Group as part of a series of working papers under the aids2031 initiative. This paper explores issues surrounding the use of antiretroviral products for the prevention of HIV, including how antiretrovirals might be used to prevent infection and potential issues emerging from such use.

Author(s): Mastro T, Cates W, Cohen M

Corporate author(s): aids2031 Science and Technology Working Group

Publication date: November 2008

Available materials

English

Antiretroviral Products for HIV Prevention: Looking Toward 2031

125 KB PDF

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

This publication is part of the series aids2031 working papers

Region: Global

See also: Emerging and epidemic diseasesHIV and AIDS

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA